Vance G. Fowler, Jr., MD, MHS

Professor of Medicine
Duke University

Vance Fowler, MD, MHS is Florence McAlister Distinguished Professor in the Departments of Medicine and Molecular Genetics & Microbiology, Duke University Medical Center. Dr. Fowler has over 2 decades of continuous support as PI from the NIH for clinical and translational research in Staphylococcus aureus and other drug-resistant bacterial infections. Dr. Fowler created the S. aureus Bacteremia Group, co-founded the International Collaboration on Endocarditis, and is Communicating PI of the Antibacterial Resistance Leadership Group.

Disclosure: Abbvie (Individual(s) Involved: Self): Grant/Research Support; Actavis (Individual(s) Involved: Self): Grant/Research Support; Advanced Liquid Logics (Individual(s) Involved: Self): Grant/Research Support; Affinergy (Individual(s) Involved: Self): Consultant, Research Grant or Support; Affinium (Individual(s) Involved: Self): Consultant; Allergan (Individual(s) Involved: Self): Grant/Research Support; Ampliphi Biosciences (Individual(s) Involved: Self): Consultant; Armata (Individual(s) Involved: Self): Consultant; Basilea (Individual(s) Involved: Self): Consultant, Research Grant or Support; Bayer: Consultant; Bayer (Individual(s) Involved: Self): Consultant; C3J (Individual(s) Involved: Self): Consultant; CARB-X (Individual(s) Involved: Self): Consultant; Cerexa (Individual(s) Involved: Self): Consultant, Research Grant or Support; Contrafect (Individual(s) Involved: Self): Consultant, Research Grant or Support; Cubist (Individual(s) Involved: Self): Grant/Research Support; Debiopharm (Individual(s) Involved: Self): Consultant; Destiny (Individual(s) Involved: Self): Consultant; Durata (Individual(s) Involved: Self): Consultant; Forest (Individual(s) Involved: Self): Grant/Research Support; Genentech (Individual(s) Involved: Self): Consultant, Research Grant or Support; ICBiome (Individual(s) Involved: Self): Consultant; Integrated Biotherapeutics (Individual(s) Involved: Self): Consultant; Janssen (Individual(s) Involved: Self): Consultant, Research Grant or Support; Karius (Individual(s) Involved: Self): Grant/Research Support; Locus (Individual(s) Involved: Self): Grant/Research Support; Medical Biosurfaces (Individual(s) Involved: Self): Grant/Research Support; Medicines Co. (Individual(s) Involved: Self): Consultant; Medimmune (Individual(s) Involved: Self): Consultant, Research Grant or Support; Merck (Individual(s) Involved: Self): Consultant, Research Grant or Support; NIH (Individual(s) Involved: Self): Grant/Research Support; Novadigm (Individual(s) Involved: Self): Consultant; Novartis (Individual(s) Involved: Self): Consultant, Research Grant or Support; Pfizer (Individual(s) Involved: Self): Grant/Research Support; Regeneron (Individual(s) Involved: Self): Consultant, Research Grant or Support; Tetraphase (Individual(s) Involved: Self): Consultant; Theravance (Individual(s) Involved: Self): Consultant, Research Grant or Support; Valanbio (Individual(s) Involved: Self): Board Member, Other Financial or Material Support, Stock options; xBiotech (Individual(s) Involved: Self): Consultant

Presentation(s):

• 36 - Maternity-associated Infective Endocarditis in the United States: Similar Outcomes to Non-pregnant Patients

  Oral Abstract

• 167 - A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple-ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients with staphylococcus Aureus Bacteremia Receiving Standard-of-care Antibiotics

  Oral Abstract

• 175 - Randomized Double-blind Controlled Trial of Short vs. Standard Course Outpatient Therapy of Community Acquired Pneumonia in Children (SCOUT-CAP)

  Oral Abstract

• 189 - Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients with staphylococcus Aureus Bacteremia: Results from a 20-year Prospective Cohort

  Oral Abstract

• 198 - Infective Endocarditis Among Solid Organ Transplant Recipients in the United States

  Oral Abstract

• Risk of Endocarditis in Patients with Staphylococcus aureus Bacteremia

  Friday, October 23, 2020
  10:00am – 11:15am EDT

• Staphylococcus aureus: Lessons Learned from 20 Years with the Persistent Pathogen

  Friday, October 23, 2020
  5:30pm – 6:00pm EDT